We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Omnicell (OMCL) USD (CDI)

Sell:$121.60 Buy:$121.69 Change: $4.07 (3.46%)
Market closed |  Prices as at close on 24 June 2022 | Switch to live prices |
Change: $4.07 (3.46%)
Market closed |  Prices as at close on 24 June 2022 | Switch to live prices |
Change: $4.07 (3.46%)
Market closed |  Prices as at close on 24 June 2022 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. The Company's point-of-care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company's Omnicell Interface Software provides interface and integration between its medication-use products or its supply products and a healthcare facility's in-house information management systems. The Company's Central Pharmacy IV Compounding Service offers a range of service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs.

Contact details

590 E Middlefield Rd
United States
+1 (650) 2516100

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$4.98 billion
Shares in issue:
44.20 million
Health Care Equipment
United States
US dollar

Key personnel

  • Randall Lipps
    Chairman of the Board, President, Chief Executive Officer
  • Peter Kuipers
    Chief Financial Officer, Executive Vice President
  • Christine Mellon
    Chief Human Resource Officer, Executive Vice President
  • Daniel Johnston
    Executive Vice President, Chief Legal and Administrative Officer
  • Scott Seidelmann
    Executive Vice President and Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.